JAK3 and autoimmune disease: Therefore, selective targeting of JAK3 has attracted many interests to prevent transplant rejection, treat various autoimmune diseases such as rheumatoid arthritis [6], ankylosing spondylitis (AS) [7], and psoriasis [8], and reduce the adverse effects of JAK1 and JAK2 inhibition [1].